title: [Low dose acetylsalicylic acid in secondary prevention of stroke].
abstract: Acetylsalicylic acid (ASA) as secondary prophylaxis after ischaemic cerebrovascular events is well established and its efficacy unquestioned since over 15 years. According to the results of two European studies a dose of 100 mg per day is sufficient to reduce the incidence of further stroke, myocardial infarction, and death due to cardiovascular causes. This satisfactory response to low-dose ASA applies to patients with transient ischaemic attacks, reversible ischaemic events, and minor strokes. In cases with severe cardiac disease, however, a high dosage of ASA or anticoagulation therapy may be necessary to prevent further vascular events.
authors.affiliation: Neurologische Universitätsklinik, Wien.
authors.forename: L
authors.initials: L
authors.lastname: Deecke
authors.forename: K
authors.initials: K
authors.lastname: Zeiler
mesh_terms: D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008134:Long-Term Care; D016032:Randomized Controlled Trials as Topic
chemical_list: D001241:Aspirin
vernacular_title: Niedrig dosierte Acetylsalizylsäure (ASS) in der Sekundärprophylaxe des Schlaganfalls.